µÏÍþ¹ú¼Ê

µÏÍþÖƵÏÍþ¹ú¼Ê µÏÍþÖƵÏÍþ¹ú¼Ê

¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • ½­ËÕºÀÉ­µÏÍþ¹ú¼ÊÒµ¼¯ÍÅÓÐÏÞ¹«Ë¾¥Y
ÐÂÎÅ·¢²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅ·¢²¼
J Diabetes Investig | Ñо¿Ê״βûÃ÷æÚÀ´ÃÀ?¸ÄÉÆT2DMÒȵºËصֿ¹ºÍÖ¬ÖÊ´úлÎÉÂÒ·Ö×Ó»úÖÆ
·¢²¼ÈÕÆÚ£º2025/05/16
×ÖºÅ
ͼƬ
½üÈÕ£¬·¢±íÔÚJournal of Diabetes Investigation£¨¡¶ÌÇÄò²¡Ñо¿ÔÓÖ¾¡·£©µÄÒ»ÏîÑо¿£¬Ê״βûÃ÷æÚÀ´ÃÀ?ͨ¹ýµ÷¿ØSRA/CNBP/ROCK2Öá¸ÄÉÆT2DMÒȵºËصֿ¹ºÍÖ¬ÖÊ´úлÎÉÂҵķÖ×Ó»úÖÆ¡£¸ÃÑо¿ÎªGLP-1ÊÜÌ弤¶¯¼ÁµÄ»úÖÆÑо¿²¹³äÁËÖØÒªÖ¤¾Ý£¬²¢Ö§³ÖæÚÀ´ÃÀ×÷Ϊ¶à°Ðµã´úлµ÷½Ú¼ÁµÄÁÙ´²Ó¦ÓÃÇ°¾°¡£

2ÐÍÌÇÄò²¡£¨T2DM£©ÊÇÒ»ÖÖÒÔÒȵºËصֿ¹¡¢¸ßѪÌǺÍÖ¬´úлÎÉÂÒΪÌØÕ÷µÄ´úлÐÔ¼²²¡£¬Æä²¢·¢Ö¢ÑÏÖØÓ°Ï컼ÕßÉú»îÖÊÁ¿¡£¾¡¹ÜÏÖÓеÏÍþ¹ú¼ÊÎÈçÒȵºËØ¡¢ÒȵºËØÔöÃô¼Á£©ÔÚÁÙ´²Öй㷺ӦÓ㬵«°ëË¥Æڶ̡¢¸±×÷ÓöàµÈÎÊÌâÏÞÖÆÁ˳¤ÆÚÁÆЧ¡£

æÚÀ´ÃÀ?£¨¾ÛÒÒ¶þ´¼ÂåÈûÄÇëÄ×¢ÉäÒº£©ÊÇÒ»ÖÖ³¤Ð§ÒȸßѪÌÇËØÑùëÄ-1£¨GLP-1£©ÊÜÌ弤¶¯¼Á£¬Ç°ÆÚÑо¿±íÃ÷Æä¾ßÓÐÏÔÖøµÄ½µÌǺ͸ÄÉÆ´úл×÷Ó㬲¢ÄܽµµÍÐÄѪ¹Ü²»Á¼Ê¼þ·çÏÕ£¬µ«Æä¶ÔѪ֬Òì³£ºÍÒȵºËصֿ¹µÄ×÷ÓûúÖÆÉÐδÍêÈ«²ûÃ÷¡£

½üÄêÀ´£¬³¤Á´·Ç±àÂëRNA£¨lncRNAs£©ÔÚ´úлµ÷¿ØÖеÄ×÷Óñ¸ÊܹØ×¢£¬ÆäÖÐÀà¹Ì´¼ÊÜÌåRNA¼¤»î¼Á£¨SRA£©±»Ö¤ÊµÓë¸ÎÔàÖ¬·¾±äÐÔºÍÒȵºËصֿ¹ÃÜÇÐÏà¹Ø¡£±¾´Î·¢±íµÄÑо¿Ö¼ÔÚ̽Ë÷æÚÀ´ÃÀ?ÊÇ·ñͨ¹ýµ÷¿ØSRA/ϸ°ûºËËá½áºÏµ°°×£¨CNBP£©/RhoÏà¹Ø¾íÇú¼¤Ã¸2£¨ROCK2£©ÐźÅÖᣬ´Ó¶ø¸ÄÉÆT2DMµÄÒȵºËصֿ¹ºÍÖ¬ÖÊ´úлÎÉÂÒ¡£

Ñо¿²ÉÓøßÖ¬ÒûʳÁªºÏÁ´ëå×ô¾úËØ£¨HFD/STZ£©ÓÕµ¼µÄT2DM´óÊóÄ£ÐÍ£¬½«Æä·ÖΪ¶ÔÕÕ×顢ģÐÍ×é¡¢µÍ¼ÁÁ¿æÚÀ´ÃÀ?×飨0.3mg/kg£©ºÍ¸ß¼ÁÁ¿æÚÀ´ÃÀ?×飨1mg/kg£©£¬Í¨¹ý´úлָ±ê¼ì²â¡¢×éÖ¯²¡Àíѧ·ÖÎö¡¢·Ö×ÓÉúÎïѧʵÑéµÈ·½·¨ÆÀ¹À¸ÉԤЧ¹û¡£½á¹û·¢ÏÖ£¬æÚÀ´ÃÀ?¾ßÓÐÏÔÖø¸ÄÉÆÒȵºËصֿ¹¡¢¾ÀÕýÖ¬ÖÊ´úлÎÉÂÒ¡¢ÒÖÖÆÑ×Ö¢ÓëÑõ»¯Ó¦¼¤µÈ×÷Ó㬲¢¿Éͨ¹ýµ÷¿ØSRA/CNBP/ROCK2Öá¸ÄÉÆT2DM¡£

Ñо¿·¢ÏÖ




ÏòÉÏ»¬¶¯ÔÄÀÀ

¡¾æÚÀ´ÃÀ?ÏÔÖø¸ÄÉÆÒȵºËصֿ¹¡¿

¸ß¼ÁÁ¿æÚÀ´ÃÀ?ÏÔÖø½µµÍT2DM´óÊóµÄ¿Õ¸¹ÑªÌÇ£¨FBG£©¡¢¿Ú·þÌÇÄÍÁ¿ÊÔÑ飨OGTT£©ÇúÏßÏÂÃæ»ý£¨AUC£©¼°¿Õ¸¹ÒȵºËØˮƽ£¨FINS£©£¬²¢½µµÍHOMA-IRÖ¸Êý£¬Í¬Ê±ÌáÉýHOMA-ISÖ¸Êý¡£µÍ¼ÁÁ¿×éÔò¶ÔÉÏÊöÖ¸±êµÄ¸ÄÉÆ×÷ÓýÏÈõ£¬ÌáʾÁÆЧ³Ê¼ÁÁ¿ÒÀÀµÐÔ¡£

¡¾æÚÀ´ÃÀ?¾ÀÕýÖ¬ÖÊ´úлÎÉÂÒ¡¿

×éÖ¯²¡ÀíÏÔʾ£¬¸ß¼ÁÁ¿æÚÀ´ÃÀ?ÏÔÖø¼õÇáT2DM´óÊóµÄ¸ÎÔàÖ¬·¾±äÐÔ£¬½µµÍ¸Î×éÖ¯ÖÐÖ¬·¾Ã¸I£¨LIPI£©µ°°×±í´ï¡£¸ß¼ÁÁ¿æÚÀ´ÃÀ?»¹¿ÉÏÔÖø½µµÍT2DM´óÊóѪÇåºÍ¸ÎÔàÖеĸÊÓÍÈýõ¥£¨TG£©¡¢×ܵ¨¹Ì´¼£¨TC£©Ë®Æ½£¬½µµÍѪÇåÊÝËØ£¨Leptin£©Ë®Æ½£¬²¢Éý¸ßÖ¬ÁªËØˮƽ¡£

¡¾æÚÀ´ÃÀ?ÒÖÖÆÑ×Ö¢ÓëÑõ»¯Ó¦¼¤¡¿

æÚÀ´ÃÀ?ÒÔ¼ÁÁ¿ÒÀÀµÐÔ·½Ê½Ïµ÷T2DM´óÊó¸ÎÔà»îÐÔÑõ£¨ROS£©Ë®Æ½£¬Ïµ÷´ÙÑ×Òò×Ó£¨TNF-¦Á¡¢IL-1¦Â¡¢IL-6£©£¬Éϵ÷¿¹Ñ×Òò×ÓIL-10ˮƽ¡£

¡¾æÚÀ´ÃÀ?ͨ¹ýµ÷¿ØSRA/CNBP/ROCK2Öá¸ÄÉÆT2DM¡¿

æÚÀ´ÃÀ?ÏÔÖøϵ÷T2DM´óÊó¸ÎÔàÖÐSRAµÄ±í´ï£¬ÇÒSRA¹ý±í´ï¿ÉÄæתæÚÀ´ÃÀ?µÄ±£»¤×÷Óá£SRAÓëCNBP¹²Í¬ÔöÇ¿ROCK2 mRNAÎȶ¨ÐÔ£¬´Ù½øRhoA/ROCK2ÐźÅͨ·¼¤»î¡£¶ø¸ß¼ÁÁ¿æÚÀ´ÃÀ?¿ÉÒÖÖƸÃͨ·£¬½µµÍROCK2µ°°×±í´ï¼°»îÐÔ£¬´Ó¶ø¸ÄÉÆÒȵºËصֿ¹ºÍÖ¬´úлÎÉÂÒ¡£

    ±¾Ñо¿Ê״βûÃ÷æÚÀ´ÃÀ?ͨ¹ýµ÷¿ØSRA/CNBP/ROCK2Öá¸ÄÉÆT2DMµÄ·Ö×Ó»úÖÆ¡£SRAÓëRhoA/ROCK2ͨ·µÄ¹ØÁª»úÖƲ»½öÏÞÓÚÌÇÄò²¡£¬»¹¿ÉÄÜΪ·Ç¾Æ¾«ÐÔÖ¬·¾¸Î£¨NAFLD£©¡¢·ÊÅֵȴúлÐÔ¼²²¡µÄÖÎÁÆÑо¿ÌṩÐÂ˼·¡£ÕâÒ»·¢ÏÖ²»½öÉÁ˶ÔGLP-1ÊÜÌ弤¶¯¼Á×÷ÓûúÖƵÄÀí½â£¬Ò²ÎªæÚÀ´ÃÀ?ÓÃÓÚ´úлÐÔ¼²²¡µÄÖÎÁÆÌṩÁËÀíÂÛÖ§³Ö¡£
    ²Î¿¼ÎÄÏ×£º
    Chen Z, Zhou Z, Wang L, Zhang Y, Huang C, Wang C, Huang Y, Wang S, Yan D, Feng K. Polyethylene glycol loxenatide modulates lipid metabolism and insulin resistance through lncRNA steroid receptor RNA activator/cellular nucleic acid binding protein/Rho-associated coiled-coil kinase 2 axis in type 2 diabetes mellitus. J Diabetes Investig. 2025 Apr;16(4):715-727.


    ÉùÃ÷£º

    1¡¢±¾¹«¸æ½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿²ÎÔÄ£¬·Ç¹ã¸æÓÃ;¡£

    2¡¢µÏÍþÖƵÏÍþ¹ú¼Ê²»ÍƼöÈκÎδ»ñÅúµÏÍþ¹ú¼ÊƷʹÓúÍ/»òδ»ñÅúÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê£¬Ò಻¶ÔÈκεÏÍþ¹ú¼ÊÆ·ºÍ/»òÊÊÓ¦Ö¢×÷ÍƼö¡£

    3¡¢±¾¹«¸æÖÐÉæ¼°µÄÐÅÏ¢½ö¹©²Î¿¼£¬Çë×ñ´ÓÒ½Éú»òÆäËûÒ½ÁÆÎÀÉúרҵÈËÊ¿µÄÒâ¼û»òÖ¸µ¼¡£Ò½ÁÆÎÀÉúרҵÈËÊ¿×÷³öµÄÈκÎÓëÖÎÁÆÓйصľö¶¨Ó¦¸ù¾Ý»¼ÕߵľßÌåÇé¿ö²¢×ñÕÕµÏÍþ¹ú¼ÊƷ˵Ã÷Êé¡£

    4¡¢ÈçÐèÁ˽⹫˾ÈκβúÆ·¡¢Ò½ÁÆ»ò¼²²¡µÄÏà¹ØÐÅÏ¢£¬ÇëÎñ±Ø×ÉѯҽÁÆÎÀÉúרҵÈËÊ¿¡£



    ¹ØÓÚµÏÍþ

    µÏÍþÖƵÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖƵÏÍþ¹ú¼ÊÆóÒµ£¬ÒÔ¡¸³ÖÐø´´Ð£¬Ìá¸ßÈËÀàÉúÃüÖÊÁ¿¡¹ÎªÊ¹Ãü£¬Öصã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò¡£½ØÖÁÄ¿Ç°£¬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬ÐγÉÁ˷ḻµÄ²úÆ·¹ÜÏß¡£µÏÍþÖƵÏÍþ¹ú¼ÊÁ¬Ðø¶àÄêλ¾ÓÈ«ÇòÖƵÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖصã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£µÏÍþÖƵÏÍþ¹ú¼ÊÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£
    ¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£



    Ç°Õ°ÐÔ˵Ã÷

    ±¾ÎÄÖ¼ÔÚÌṩÓйء°µÏÍþÖƵÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¡±»òÆä×Ó¹«Ë¾µÈ¹ØÁª·½£¨Í³³Æ¡°¹«Ë¾¡±£©µÄÏà¹ØÐÅÏ¢£¬²»¹¹³É¹«Ë¾ÐÅÏ¢Åû¶»òͶ×ÊÍƼö¡£

    ±¾ÎÄËù·¢²¼µÄÐÅÏ¢ÖпÉÄÜ»á°üº¬Ä³Ð©Ç°Õ°ÐÔ±íÊö£¬ÀýÈçÉæ¼°ÒµÎñºÍ²úÆ·Ç°¾°£¬»ò¹«Ë¾¼Æ»®¡¢ÈÏÖª¡¢Ô¤ÆÚ¼°²ßÂÔ¡£ÕâЩ±íÊöÊǽ¨Á¢ÔÚÍƲâÐÔ¼ÙÉèµÄÊý¾Ý»ù´¡ÉϵÄÔ¤²â£¬²¢·ÇÊǶÔδÀ´·¢Õ¹µÄ±£Ö¤£¬ÒòÆäÐÔÖÊʹȻ¾ùÊÜÏà¹Ø·çÏպͲ»È·¶¨ÒòËØÓ°Ï죬ÆäÖв¿·Ö»¹²»Êܹ«Ë¾¿ØÖÆÇÒÄÑÒÔÔ¤ÁÏ£¬Í¶×ÊÕß½øÐÐͶ×ʾö²ßʱӦ½÷É÷ʹÓá£ÔÚʹÓá°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°ÆÚÍû¡±¼°ÆäËûÀàËÆ´ÊÓï½øÐбíÊöʱ£¬·²Ó빫˾ÓйصÄÐÅÏ¢±íÊö£¬¾ùÊôÓÚÇ°Õ°ÐÔ±íÊö¡£¹«Ë¾²¢ÎÞÒåÎñ¸üлòÐÞ¸ÄÕâЩǰհÐÔ±íÊö£¬¹«Ë¾¡¢¹«Ë¾¶­Ê¡¢¹ÍÔ±¡¢´úÀí¸Å²»³Ðµ£ÒòÈκÎÇ°Õ°ÐÔ±íÊö²»ÄÜʵÏÖ»ò±ä³É²»ÕýÈ·¶øÒýÖµÄÈκÎÔðÈΡ£

    ±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢½ö¼°ÓÚÐÂΟ巢²¼Ö®ÈÕ£¬ÎÞÂÛÊÇ·ñ³öÏÖÐÂ×ÊÁÏ¡¢Î´À´Ê¼þ»òÆäËûÇé¿ö£¬³ý·Ç·¨ÂÉÒªÇ󣬹«Ë¾²¢ÎÞÔðÈλòÒåÎñ¸üлòÐ޸ĸõÈÐÅÏ¢¡£Í¶×ÊÕßÒ˲ÎÕÕµÏÍþÖƵÏÍþ¹ú¼Ê£¨03692.HK£©¹«¸æ¼°²Æ±¨£¬ÒÔ»ñÈ¡½öÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢¡£

    ¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿